Quarterly report pursuant to Section 13 or 15(d)

RELATED PARTY TRANSACTIONS (Details Narrative)

v3.8.0.1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 7 Months Ended
Jun. 24, 2016
Jan. 01, 2016
Oct. 21, 2015
Dec. 20, 2013
Jul. 31, 2016
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Mr. Andrew I. Sealfon [Member] | Lease Agreement [Member] | Aircraft [Member]                  
Lease payments           $ 3,876 $ 5,375 $ 9,544 $ 12,542
Mr. Mark Pastreich [Member] | Lease Agreement [Member] | Building [Member]                  
Monthly lease payments               11,042 11,042
Lease payments           33,126 33,126 77,294 77,294
Property taxes paid           12,862 12,334 29,098 28,159
Clinical Research & Support Services Consulting Agreement [Member] | Dr. Mark Baker [Member]                  
Amortization of deferred compensation cost           0 7,000 0 14,000
Clinical Research & Support Services Consulting Agreement [Member] | FREEDOM60 Syringe Infusion System [Member] | Dr. Mark Baker [Member]                  
Number of shares issued upon agreement       420,000          
Share price (in dollars per share)       $ 0.20          
Agreement term       3 years          
Consulting Agreement [Member] | Mr. Cyril Narishkin [Member]                  
Monthly payment for agreement   $ 16,000 $ 16,000            
Description of payment terms  

Seventy-five percent was to be paid in cash and twenty-five percent was to be paid in shares of common stock.

Half was to be paid in cash and half was to be paid in shares of common stock.

           
Consulting Agreement [Member] | Mr. Cyril Narishkin (Consultant) [Member]                  
Monthly payment for agreement $ 16,000                
Number of shares repurchased         96,542        
Value of shares repurchased         $ 43,393        
Officer compensation           $ 0 $ 48,000 $ 0 $ 166,000